Flynn Sean C.
Transaction: 06/26/2026
SELL
Change
-15,000
Price
$45.64
Filing
06/30/2026
Type
SELL
Vericel Corporation
VCEL • Biotechnology
$40.58
▲ +0.21 (+0.52%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.43B
Growth
-5.4%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 12.9%Positive free cash flow · 0.49Consistent free cash flow · 4/5Manageable debt level · 0.28Healthy liquidity · 5.03
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$40.58
Change0.52%
Market Cap$2.43B
52W Range28.95 - 49.32
Beta1.07
Gross Margin74.42%
Oper. Margin4.00%
Profit Margin5.98%
Debt/Eq0.28
Current Ratio5.03
Quick Ratio4.68
Revenue 5Y-5.44%
Price$40.58
Change0.52%
Market Cap$2.43B
52W Range28.95 - 49.32
Beta1.07
Gross Margin74.42%
Oper. Margin4.00%
Profit Margin5.98%
Debt/Eq0.28
Current Ratio5.03
Quick Ratio4.68
Revenue 5Y-5.44%
Target$57.50
Target Upside41.70%
Target Median$57.00
Target Range46.00 - 70.00
Volume964.38K
Avg Volume630.00K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
59
out of 100
Business Quality
Margins, moat, returns
47/100
Financial Strength
Debt, cash, stability
90/100
Growth Potential
Revenue and expansion
71/100
Price Attractiveness
Cheap or expensive today
34/100
Why this score▼
Positive revenue growth · 12.9%Positive free cash flow · 0.49Consistent free cash flow · 4/5Manageable debt level · 0.28Healthy liquidity · 5.03Expensive earnings multiple · 110.29
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$46.00
Mean
$57.50
Median
$57.00
High
$70.00
Insider Transactions
Recent executive and insider activity
Flynn Sean C.
Transaction: 06/26/2026
BUY
Change
+15,000
Price
$16.25
Filing
06/30/2026
Type
BUY
Hopper Jonathan Mark
Transaction: 06/26/2026
BUY
Change
+5,000
Price
$29.82
Filing
06/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Flynn Sean C. | SELL | -15,000 | $45.64 | 06/26/2026 | 06/30/2026 |
| Flynn Sean C. | BUY | +15,000 | $16.25 | 06/26/2026 | 06/30/2026 |
| Hopper Jonathan Mark | BUY | +5,000 | $29.82 | 06/26/2026 | 06/30/2026 |
| Hopper Jonathan Mark | SELL | -5,000 | $45.00 | 06/26/2026 | 06/30/2026 |
| Mara Joseph Anthony Jr | SELL | -5,000 | $44.75 | 06/26/2026 | 06/30/2026 |
| SIEGAL JONATHAN | SELL | -2,500 | $44.90 | 06/26/2026 | 06/30/2026 |
| SIEGAL JONATHAN | BUY | +2,500 | $29.82 | 06/26/2026 | 06/30/2026 |
| Flynn Sean C. | SELL | -15,000 | $40.21 | 06/18/2026 | 06/22/2026 |
| Flynn Sean C. | BUY | +15,000 | $16.25 | 06/18/2026 | 06/22/2026 |
| Halpin Michael | SELL | -10,000 | $40.24 | 06/18/2026 | 06/22/2026 |
| Halpin Michael | BUY | +10,000 | $16.66 | 06/18/2026 | 06/22/2026 |
| Hopper Jonathan Mark | BUY | +4,375 | $16.66 | 06/02/2026 | 06/04/2026 |
| Hopper Jonathan Mark | SELL | -4,375 | $35.00 | 06/02/2026 | 06/04/2026 |
| MCLAUGHLIN KEVIN F | BUY | +3,500 | $2.63 | 05/13/2026 | 05/15/2026 |
| MCLAUGHLIN KEVIN F | SELL | -3,500 | $32.82 | 05/13/2026 | 05/15/2026 |
| Wotton Paul K | SELL | -7,500 | $32.64 | 05/11/2026 | 05/13/2026 |
| SIEGAL JONATHAN | SELL | -1,422 | $40.50 | 05/07/2026 | 05/08/2026 |
| Mara Joseph Anthony Jr | SELL | -5,000 | $40.50 | 05/07/2026 | 05/08/2026 |
| SIEGAL JONATHAN | SELL | -3,433 | $38.00 | 05/06/2026 | 05/08/2026 |
| ZERBE ROBERT L MD | BUY | +3,200 | Not reported | 04/29/2026 | 05/01/2026 |